Consent Is a Conversation, Not a Signature

The informed consent form gets the regulatory attention, but the consent conversation determines whether a participant truly understands what they're joining — and whether they'll still be in the study six months later.

Why rushed consent backfires

A participant who signs without absorbing the visit schedule, washout requirements, or randomization odds hasn't really enrolled; they've deferred their decision to the first inconvenient visit. Early withdrawals cluster among participants who later say they "didn't realize" some core feature of the study. That's not a retention problem. It's a consent problem that showed up late.

Running a better conversation

Send the ICF ahead of the visit. Reading 20 pages for the first time across a desk, with a coordinator waiting, is not comprehension — it's performance. Give people days, not minutes.

Use teach-back. Instead of "any questions?", ask "just so I know I explained it well — can you tell me in your own words what happens if you're randomized to placebo?" Teach-back reliably surfaces the misunderstandings that matter.

Name the burdens explicitly. Coordinators naturally emphasize benefits and soften burdens. Resist it. "You'll come in fourteen times over a year, and four visits include a two-hour infusion" said plainly now prevents a dropout later.

Document the dialogue. Note the questions asked and materials used. If comprehension is ever questioned — by an IRB, a monitor, or a family member — the record of a genuine conversation is the site's best evidence.

Consent doesn't end at signature

Re-consent at amendments is the obvious case, but good sites also re-ground participants at burden inflection points: before the first overnight stay, before the washout. Thirty seconds of "here's what's coming, still comfortable?" is cheap insurance on the site's most expensive asset — an enrolled participant.